Esitamat 20 Tablet contains Escitalopram Oxalate 20 mg, a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD). Escitalopram functions by increasing the extracellular level of serotonin in the central nervous system, thereby enhancing serotonergic neurotransmission which is believed to contribute to its antidepressant and anxiolytic effects. This medication is prescribed to alleviate symptoms such as persistent sadness, loss of interest, anxiety, and associated cognitive and physical symptoms. Esitamat 20 is typically administered once daily, with or without food, and dosage adjustments should be individualized based on clinical response and tolerability. Common adverse effects may include nausea, headache, insomnia, fatigue, and sexual dysfunction, while serious side effects such as serotonin syndrome, hyponatremia, and increased risk of suicidal ideation require immediate medical attention. Caution is advised in patients with a history of bipolar disorder, seizures, or hepatic impairment. Esitamat 20 should not be abruptly discontinued to avoid withdrawal symptoms. It is contraindicated with monoamine oxidase inhibitors (MAOIs) and other serotonergic agents. Regular monitoring by a healthcare professional is essential to ensure efficacy and safety during treatment.